For: | Alexopoulou A, Papatheodoridis GV. Current progress in the treatment of chronic hepatitis C. World J Gastroenterol 2012; 18(42): 6060-6069 [PMID: 23155334 DOI: 10.3748/wjg.v18.i42.6060] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i42/6060.htm |
Number | Citing Articles |
1 |
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak. Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C. International Journal of Infectious Diseases 2016; 50: 1 doi: 10.1016/j.ijid.2016.07.003
|
2 |
Kyoko Saito, Yoshitaka Shirasago, Tetsuro Suzuki, Hideki Aizaki, Kentaro Hanada, Takaji Wakita, Masahiro Nishijima, Masayoshi Fukasawa, S. Perlman. Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C Virus. Journal of Virology 2015; 89(4): 2220 doi: 10.1128/JVI.03385-14
|
3 |
Nicole Balasco, Daniela Barone, Emanuela Iaccarino, Annamaria Sandomenico, Alfonso De Simone, Menotti Ruvo, Luigi Vitagliano. Intrinsic structural versatility of the highly conserved 412–423 epitope of the Hepatitis C Virus E2 protein. International Journal of Biological Macromolecules 2018; 116: 620 doi: 10.1016/j.ijbiomac.2018.05.055
|
4 |
Carolina Scagnolari, Guido Antonelli. Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C. Expert Opinion on Biological Therapy 2013; 13(5): 693 doi: 10.1517/14712598.2013.764409
|
5 |
Evangelos Cholongitas, Chrysoula Pipili, George Papatheodoridis. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World Journal of Gastroenterology 2015; 21(32): 9526-9533 doi: 10.3748/wjg.v21.i32.9526
|
6 |
Keisuke Osakabe, Naohiro Ichino, Toru Nishikawa, Hiroko Sugiyama, Miho Kato, Ai Shibata, Wakana Asada, Naoto Kawabe, Senju Hashimoto, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Toshiki Kan, Kazunori Nakaoka, Yuka Takagawa, Masashi Ohki, Takamitsu Kurashita, Tomoki Takamura, Kentaro Yoshioka. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. World Journal of Gastroenterology 2015; 21(35): 10215-10223 doi: 10.3748/wjg.v21.i35.10215
|
7 |
Longbo Hu, Wenxia Yao, Fang Wang, Xia Rong, Tao Peng, Hong Wanjin. GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion. PLoS ONE 2014; 9(3): e90553 doi: 10.1371/journal.pone.0090553
|
8 |
Francisco Jorquera, Francisco Ledesma, Adriana Ahumada, María Luisa Manzano, Agustín Castiella, Sara Lorente, Mireia Miquel, Zoe Mariño, José Castellote, Eva Sanz, Juan Uriz. Perfil clínico de los pacientes españoles con hepatitis C naïve con cirrosis compensada tratados en el estudio CREST. Gastroenterología y Hepatología 2024; 47(6): 605 doi: 10.1016/j.gastrohep.2024.02.003
|
9 |
Amaravadhi Harikishore, Enlin Li, Jia Jun Lee, Nam-Joon Cho, Ho Sup Yoon. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase. Molecular Diversity 2015; 19(3): 529 doi: 10.1007/s11030-015-9591-5
|
10 |
Chrysoula Pipili, Evangelos Cholongitas. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?. World Journal of Hepatology 2015; 7(12): 1606-1616 doi: 10.4254/wjh.v7.i12.1606
|
11 |
Ammar Y. Abdulrahman, Hussin A. Rothan, Nurshamimi Nor Rashid, See Khai Lim, Wajihah Sakhor, Kah Ching Tee, Teow Chong Teoh, Noorsaadah A. Rahman, Rohana Yusof. Identification of Peptide Leads to Inhibit Hepatitis C Virus: Inhibitory Effect of Plectasin Peptide Against Hepatitis C Serine Protease. International Journal of Peptide Research and Therapeutics 2017; 23(2): 163 doi: 10.1007/s10989-016-9544-6
|
12 |
Ulrike Grienke, Teresa Kaserer, Florian Pfluger, Christina E. Mair, Thierry Langer, Daniela Schuster, Judith M. Rollinger. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling. Phytochemistry 2015; 114: 114 doi: 10.1016/j.phytochem.2014.10.010
|
13 |
Deena S. Lasheen, Mohamed A.H. Ismail, Dalal A. Abou El Ella, Nasser S.M. Ismail, Sameh Eid, Susan Vleck, Jeffrey S. Glenn, Andrew G. Watts, Khaled A.M. Abouzid. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity. Bioorganic & Medicinal Chemistry 2013; 21(10): 2742 doi: 10.1016/j.bmc.2013.03.017
|
14 |
Francisco Jorquera, Francisco Ledesma, Adriana Ahumada, María Luisa Manzano, Agustín Castiella, Sara Lorente, Mireia Miquel, Zoe Mariño, José Castellote, Eva Sanz, Juan Uriz. Clinical profile of Spanish hepatitis C virus-infected treatment-naïve patients with compensated cirrhosis in the CREST study. Gastroenterología y Hepatología (English Edition) 2024; 47(6): 605 doi: 10.1016/j.gastre.2024.04.019
|
15 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
16 |
Clara Weil, Chizoba Nwankwo, Mira Friedman, Gabriel Kenet, Gabriel Chodick, Varda Shalev. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization. Journal of Medical Virology 2016; 88(6): 1044 doi: 10.1002/jmv.24426
|
17 |
George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke, Heiner Wedemeyer. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review. Liver International 2014; 34(10): 1452 doi: 10.1111/liv.12565
|
18 |
Makoto Ocho, Akira Togayachi, Etsuko Iio, Hiroyuki Kaji, Atsushi Kuno, Maki Sogabe, Masaaki Korenaga, Masanori Gotoh, Yasuhito Tanaka, Yuzuru Ikehara, Masashi Mizokami, Hisashi Narimatsu. Application of a Glycoproteomics-Based Biomarker Development Method: Alteration in Glycan Structure on Colony Stimulating Factor 1 Receptor as a Possible Glycobiomarker Candidate for Evaluation of Liver Cirrhosis. Journal of Proteome Research 2014; 13(3): 1428 doi: 10.1021/pr400986t
|
19 |
A. Hatzakis, P. Van Damme, K. Alcorn, C. Gore, M. Benazzouz, S. Berkane, M. Buti, M. Carballo, H. Cortes Martins, S. Deuffic‐Burban, A. Dominguez, M. Donoghoe, A‐N. Elzouki, N. Ben‐Alaya Bouafif, G. Esmat, R. Esteban, M. Fabri, K. Fenton, D. Goldberg, I. Goulis, T. Hadjichristodoulou, T. Hatzigeorgiou, O. Hamouda, S. Hasurdjiev, S. Hughes, A. Kautz, M. Malik, S. Manolakopoulos, M. Matičič, G. Papatheodoridis, R. Peck, A. Peterle, G. Potamitis, D. Prati, F. Roudot‐Thoraval, T. Reic, A. Sharara, M. Shennak, G. Shiha, D. Shouval, M. Sočan, H. Thomas, M. Thursz, M. Tosti, C. Trépo, A. Vince, E. Vounou, L. Wiessing, M. Manns. The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference. Journal of Viral Hepatitis 2013; 20(s2): 1 doi: 10.1111/jvh.12120
|
20 |
Marcos Alexandre Nobre Lemos, Sandra Fernanda Suarez Patiño, Thaissa Consoni Bernardino, Ana Sofia Coroadinha, Hugo Soares, Renato Mancini Astray, Carlos Augusto Pereira, Soraia Attie Calil Jorge. Intracellular Delivery of HCV NS3p gene using vectored particles. Journal of Biotechnology 2018; 274: 33 doi: 10.1016/j.jbiotec.2018.03.010
|
21 |
Ս․Ռ․ Սարգսյան. ՔՐՈՆԻԿ ՎԻՐՈՒՍԱՅԻՆ C ՀԵՊԱՏԻՏ. ՀԱԿԱՎԻՐՈՒՍԱՅԻՆ ԲՈՒԺՄԱՆ ՓՈՒԼԵՐԸ (ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ). MEDICINE, SCIENCE AND EDUCATION 2022; (33): 22 doi: 10.56936/18291775-2022.33-22
|